Quercetin and baicalein suppress monocrotaline-induced hepatic sinusoidal obstruction syndrome in rats

European Journal of Pharmacology

Volumn 795, Issue , 2017, Pages 160-168

  Zhang, Jiaqi ^a   Sheng, Yuchen ^a   Shi, Liang ^a   Zheng, Zhiyong ^a   Chen, Minwei ^a   Lu, Bin ^a   Ji, Lili ^a  

^a SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Egr1; MAPKs; Nrf2; PI3K; Sinusoidal obstruction syndrome; TLRs NF B

Indexed keywords

BAICALEIN; EARLY GROWTH RESPONSE FACTOR 1; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MALONALDEHYDE; MITOGEN ACTIVATED PROTEIN KINASE; MONOCROTALINE; MYELOPEROXIDASE; PHOSPHATIDYLINOSITOL 3 KINASE; QUERCETIN; SERINE PROTEINASE INHIBITOR; THROMBOPLASTIN; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR 9; EGR1 PROTEIN, RAT; FLAVANONE DERIVATIVE; NFE2L2 PROTEIN, RAT; PROTEIN KINASE B; TOLL LIKE RECEPTOR; TRANSCRIPTION FACTOR NRF2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVATION; LIVER PROTECTION; LIVER VENOOCCLUSIVE DISEASE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TRANSCRIPTION INITIATION; ANIMAL; CHEMICALLY INDUCED; DRUG EFFECTS; HEPATIC VENO-OCCLUSIVE DISEASE; METABOLISM; OXIDATIVE STRESS; SIGNAL TRANSDUCTION;

ANIMALS; EARLY GROWTH RESPONSE PROTEIN 1; FLAVANONES; HEPATIC VENO-OCCLUSIVE DISEASE; MALE; MAP KINASE SIGNALING SYSTEM; MONOCROTALINE; NF-E2-RELATED FACTOR 2; NF-KAPPA B; OXIDATIVE STRESS; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; QUERCETIN; RATS; TOLL-LIKE RECEPTORS;

EID: 85008873231     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2016.12.015     Document Type: Article

References (47)

1. Aljada, A., Ghanim, H., Mohanty, P., Kapur, N., Dandona, P., Insulin inhibits the pro-inflammatory transcription factor early growth response gene-1 (Egr)-1 expression in mononuclear cells (MNC) and reduces plasma tissue factor (TF) and plasminogen activator inhibitor-1 (PAI-1) concentrations. J. Clin. Endocrinol. Metab. 87 (2002), 1419–1422.
2. Baeuerle, P.A., Baltimore, D., IkappaB: a specific inhibitor of the NF-kappaB transcription factor. Science 242 (1998), 540–546.
3. Baeuerle, P.A., Henkel, T., Function and activation of NF-kappaB in the immune system. Annu. Rev. Immunol. 12 (1994), 141–179.
4. Broering, R., Lu, M., Schlaak, J.F., Role of Toll-like receptors in liver health and disease. Clin. Sci. 121 (2011), 415–426.
5. Bryan, H.K., Olayanju, A., Goldring, C.E., Park, B.K., The Nrf2 cell defence pathway: keap1-dependent and -independent mechanisms of regulation. Biochem. Pharmacol. 85 (2013), 705–717.
6. Carreras, E., How I manage sinusoidal obstruction syndrome after haematopoietic cell transplantation. Br. J. Haematol. 168 (2015), 481–491.
7. Chen, P.H., Wang, Y., Chen, L.L., Jiang, W., Niu, Y., Shao, Q., Comparison of the anti-inflammatory active constituents and hepatotoxic pyrrolizidine alkaloids in two Senecio plants and their preparations by LC-UV and LC-MS. J. Pharm. Biomed. 115 (2015), 260–271.
8. Chen, Z., Huo, J.R., Yang, L., Zhu, H.Y., Effect of ligustrazine on mice model of hepatic veno-occlusive disease induced by Gynura segetum. J. Gastroenterol. Hepatol. 26 (2011), 1016–1021.
9. Chiao, H., Foster, S., Thomas, R., Lipton, J., Star, R.A., Alpha-melanocyte- stimulating hormone reduces endotoxin-induced liver inflammation. J. Clin. Invest. 97 (1996), 2038–2044.
10. Conotte, R., Colet, J.M., A metabonomic evaluation of the monocrotaline-induced sinusoidal obstruction syndrome (SOS) in rats. Toxicol. Appl. Pharmacol. 276 (2014), 147–156.
11. Coppell, J.A., Richardson, P.G., Soiffer, R., Martin, P.L., Kernan, N.A., Chen, A., Hepatic veno-occlusive disease following stem cell transplantation: incidence, clinical course, and outcome. Biol. Blood Marrow Transplant. 16 (2010), 157–168.
12. Dai, N., Yu, Y.C., Ren, T.H., Wu, J.G., Jiang, Y., Shen, L.G., Gynura root induces hepatic veno-occlusive disease: a case report and review of the literature. World J. Gastroenterol. 13 (2007), 1628–1631.
13. DeLeve, L.D., McCuskey, R.S., Wang, X.D., Hu, L.P., McCuskey, M.K., Epstein, R.B., Kanel, C.C., Characterization of a reproducible rat model of hepatic veno-occlusive disease. Hepatology 29 (1999), 1779–1991.
14. DeLeve, L.D., Shulman, H.M., McDonald, G.B., Toxic injury to hepatic sinusoids: sinusoidal obstruction syndrome (veno-occlusive disease). Semin. Liver Dis. 22 (2002), 27–42.
15. Deleve, L.D., Wang, X., Tsai, J., Kanel, G., Strasberg, S., Tokes, Z.A., Sinusoidal obstruction syndrome (veno-occlusive disease) in the rat is prevented by matrix metalloproteinase inhibition. Gastroenterology 125 (2003), 882–890.
16. Domitrović, R., Jakovac, H., Vasiljev Marchesi, V., Vladimir-Knežević, S., Cvijanović, O., Tadić, Z., Differential hepatoprotective mechanisms of rutin and quercetin in CCl(4)-intoxicated BALB/cN mice. Acta Pharmacol. Sin. 33 (2012), 1260–1270.
17. Ezzat, T., van, den, Broek, M.A., Davies, N., Dejong, C.H., Bast, A., Malaqo, M., The flavonoid monoHER prevents monocrotaline-induced hepatic sinusoidal injury in rats. J. Surg. Oncol. 106 (2012), 72–78.
18. Hanumegowda, U.M., Copple, B.L., Shibuya, M., Malle, E., Ganey, P.E., Roth, R.A., Basement membrane and matrix metalloproteinases in monocrotaline-induced liver injury. Toxicol. Sci. 76 (2003), 237–246.
19. Helmy, A., Review article: updates in the pathogenesis and therapy of hepatic sinusoidal obstruction syndrome. Aliment. Pharmacol. Ther. 23 (2006), 11–25.
20. Hollman, P.C.H., Katan, M.B., Dietary flavonoids: intake, health effects and bioavailability. Food Chem. Toxicol. 37 (1999), 937–942.
21. Huang, H.L., Wang, Y.J., Zhang, Q.Y., Liu, B., Wang, F.Y., Li, J.J., Hepatoprotective effects of baicalein against CCl(4)-induced acute liver injury in mice. World J. Gastroenterol. 18 (2012), 6605–6613.
22. Kaleelrahman, M., Eatonm, J.D., Leeming, D., Bowyer, K., Taberner, D., Chang, J., Role of plasminogen activator inhibitor-1 (PAI-1) levels in the diagnosis of BMT-associated hepatic veno-occlusive disease and monitoring of subsequent therapy with defibrotide (DF). Hematology 8 (2003), 91–95.
23. Keating, G.M., Defibrotide: a review of its use in severe hepatic veno-occlusive disease following haematopoietic stem cell transplantation. Clin. Drug Investig. 34 (2014), 895–904.
24. Klebanoff, S.J., Myeloperoxidase: friend and foe. J. Leukoc. Biol. 77 (2005), 598–625.
25. Lee, J.H., Lee, K.H., Lee, J.H., Kim, S., Seol, M., Park, C.J., Plasminogen activator inhibitor-1 is an independent diagnostic marker as well as severity predictor of hepatic veno-occlusive disease after allogeneic bone marrow transplantation in adults conditioned with busulphan and cyclophosphamide. Br. J. Haematol. 118 (2002), 1087–1094.
26. Liu, C., Calogero, A., Ragona, G., Adamson, E., Mercola, D., EGR-1, the reluctant suppression factor: EGR-1 is known to function in the regulation of growth, differentiation, and also significant tumor suppressor activity and a mechanism involving the induction of TGF-beta1 is postulated to account for this suppressor activity. Crit. Rev. Oncog. 7 (1996), 101–125.
27. McGee, J., Patrick, R.S., Wood, C.B., Blumqart, L.H., A case of veno-occlusive disease of the liver in Britain associated with herbal tea consumption. J. Clin. Pathol. 29 (1976), 788–794.
28. Mordret, G., MAP kinase kinase: a node connecting multiple pathways. Biol. Cell 79 (1993), 193–207.
29. Nakamura, K., Hatano, E., Narita, M., Miyaqawa-Hayashino, A., Koyama, Y., Naqata, H., Sorafenib attenuates monocrotaline-induced sinusoidal obstruction syndrome in rats through suppression of JNK and MMP-9. J. Hepatol. 57 (2012), 1037–1043.
30. Okuno, M., Hatano, E., Nakamura, K., Miyagawa-Hayashino, A., Kasai, Y., Nishio, T., Regorafenib suppresses sinusoidal obstruction syndrome in rats. J. Surg. Res. 193 (2015), 693–703.
31. Park, E.J., Pezzuto, J.M., Flavonoids in cancer prevention. Anticancer Agents Med. Chem. 12 (2012), 836–851.
32. Periasamy, S., Hsu, D.Z., Chen, S.Y., Yang, S.S., Chandrasekaran, V.R., Liu, M.Y., Therapeutic sesamol attenuates monocrotaline-induced sinusoidal obstruction syndrome in rats by inhibiting matrix metalloproteinase-9. Cell Biochem. Biophys. 61 (2011), 327–336.
33. Robinson, S.M., Mann, J., Vasilaki, A., Mathers, J., Burt, A.D., Oakley, F., Pathogenesis of FOLFOX induced sinusoidal obstruction syndrome in a murine chemotherapy model. J. Hepatol. 59 (2013), 318–326.
34. Rubbia-Brandt, L., Audard, V., Sartoretti, P., Roth, A.D., Brezault, C., Le, Charpentier, M., Severe hepatic sinusoidal obstruction associated with oxaliplatin based chemotherapy in patients with metastatic colorectal cancer. Ann. Oncol. 15 (2004), 460–466.
35. Ruiz-Vasquez, L., Reina, M., Lopez-Rodriguez, M., Gimenez, C., Cabrera, R., Cuadra, P., Sesquiterpenes, flavonoids, shikimic acid derivatives and pyrrolizidine alkaloids from Senecio kingii Hook. Phytochemistry 117 (2015), 245–253.
36. Seow, L.J., Beh, H.K., Umar, M.I., Sadikun, A., Asmawi, M.Z., Ant-inflammatory and antioxidant activities of the methanol extract of Gynura segetum leaf. Int. Immunopharm. 23 (2014), 186–191.
37. Takeda, K., Kaisho, T., Akira, S., Toll-like receptors. Annu. Rev. Immunol. 21 (2003), 335–376.
38. Tang, Y., Li, Y., Yu, H., Gao, C., Liu, L., Xing, M., Quercetin attenuates chronic ethanol hepatotoxicity: implication of “free” iron uptake and release. Food Chem. Toxicol. 67 (2014), 131–138.
39. Torres, M., Forman, H.J., Redox signaling and the MAP kinase pathways. Biofactors 17 (2003), 287–296.
40. Troutman, T.D., Bazan, J.F., Pasare, C., Toll-like receptors, signaling adapters and regulation of the pro-inflammatory response by PI3K. Cell Cycle 11 (2012), 3559–3567.
41. Vion, A.C., Rautou, P.E., Durand, F., Boulanger, C.M., Valla, D.C., Interplay of inflammation and endothelial dysfunction in bone marrow transplantation: Focus on hepatic veno-occlusive disease. Semin. Thromb. Hemost. 41 (2015), 629–643.
42. Wadleigh, M., Ho, V., Momtaz, P., Richardson, P., Hepatic veno-occlusive disease: pathogenesis, diagnosis and treatment. Curr. Opin. Hematol. 10 (2003), 451–462.
43. Wang, D.W., Huang, L.F., Chen, S.L., Senecio scandens Buch.-Ham.: a review on its ethnopharmacology, phytochemistry, pharmacology, and toxicity. J. Ethnopharmacol. 149 (2013), 1–23.
44. Wang, J.Y., Gao, H., Tusanqi and hepatic sinusoidal syndrome. J. Dig. Dis. 15 (2014), 105–107.
45. Wang, X., Qi, X., Guo, X., Tusanqi-related sinusoidal obstruction syndrome in China: a systematic review of the literatures. Medicine, 94, 2015, e942.
46. Willmot, F.C., Robertson, G.W., Senecio disease, or cirrhosis of the liver due to senecio poisoning. Lancet 196 (1920), 848–849.
47. Zhang, Q., Pi, J.B., Wood, C.G., Andersen, M.E., A systems biology perspective on Nrf2-mediated antioxidant response. Toxicol. Appl. Pharmacol. 244 (2010), 84–97.